Qinecsa

Qinecsa is a global pharmacovigilance specialist headquartered in the UK, with over 1,300 employees. The company combines more than 20 years of scientific expertise with a technology-powered platform to address complex drug safety challenges. Qinecsa serves pharmaceutical companies, biotech organisations, and public health and regulatory bodies worldwide, providing end-to-end pharmacovigilance solutions aimed at elevating patient safety standards and simplifying compliance management.

Qinecsa's heritage draws from three established safety providers — Commonwealth Informatics, Bioclinica DSS, and MyMeds & Me — whose combined capabilities form the foundation of its current integrated offering. Operating as a dedicated, independent pharmacovigilance partner, the company focuses on reducing fragmentation in drug safety operations and delivering greater clarity and accountability across the life sciences sector.

Core Focus Areas

• End-to-end pharmacovigilance solutions combining scientific expertise with technology
• Adverse event management, with an emphasis on moving from reactive reporting to proactive patient protection
• Drug safety surveillance and compliance management for life sciences companies and health authorities
• Integration of safety solutions across life science companies, public health organisations, and regulatory sectors

Mission and Strategic Approach

• Mission centres on empowering life sciences organisations with integrated safety solutions that elevate surveillance and simplify compliance
• Aims to transform adverse event management from a reactive obligation into a proactive force for patient protection
• Vision is to set a global standard for pharmacovigilance by uniting scientific expertise and advanced technology
• Seeks to build a more connected and accountable drug safety ecosystem for patients worldwide

Company Profile and Values

• Headquartered in the United Kingdom with a global operational footprint
• Employs more than 1,300 people across its operations
• Trusted by leading life sciences companies and health authorities internationally
• Operates as an independent pharmacovigilance partner, not affiliated with a larger pharmaceutical or CRO group
• Company values include integrity, innovation, respect, care and empowerment, passion, and openness and collaboration
• Emphasises long-term relationships with life sciences clients built on trust and scientific credibility